T1	tradename 0 8	AMPHOTEC
T2	activeingredient 8 22	Amphotericin B
T3	tradename 64 73	AMPHOTEC-
T4	activeingredient 74 88	amphotericin b
T5	nanoparticle 100 113	lipid complex
T6	tradename 140 148	AMPHOTEC
T7	activeingredient 148 162	Amphotericin B
T8	tradename 224 224	
T9	routeofadministration 295 325	intravenous (IV)administration
T10	tradename 327 335	AMPHOTEC
T11	activeingredient 379 393	amphotericin B
T12	tradename 439 447	AMPHOTEC
T13	nanoparticle 456 465	colloidal
T14	nanoparticle 519 528	Liposomal
T15	nanoparticle 567 580	lipid complex
T16	nanoparticle 735 744	liposomal
T17	nanoparticle 748 761	lipid-complex
T18	activeingredient 980 994	Amphotericin B
T19	indication 1001 1011	antifungal
T20	activeingredient 1076 1091	Amphotericin B,
T21	molecularweight 1521 1528	924.10.
T22	tradename 1528 1536	AMPHOTEC
T23	activeingredient 1637 1640	 B,
T24	inactiveingredient 1648 1675	sodium cholesteryl sulfate,
T25	inactiveingredient 1685 1698	tromethamine,
T26	inactiveingredient 1708 1734	disodium edetatedihydrate,
T27	inactiveingredient 1745 1765	lactose monohydrate,
T28	inactiveingredient 1778 1796	hydrochloric acid,
T29	activeingredient 1886 1901	amphotericin B,
T30	inactiveingredient 1909 1936	sodium cholesteryl sulfate,
T31	inactiveingredient 1946 1959	tromethamine,
T32	inactiveingredient 1970 1997	disodium edetate dihydrate,
T33	inactiveingredient 2007 2027	lactose monohydrate,
T34	inactiveingredient 2041 2059	hydrochloric acid,
T35	tradename 2167 2176	AMPHOTEC,
T36	activeingredient 2177 2192	amphotericin B,
T37	activeingredient 2424 2438	Amphotericin B
T38	tradename 2621 2621	
T39	indication 2649 2660	Aspergillus
T40	indication 2665 2681	Candida species.
T41	indication 2740 2759	Aspergillus species
T42	indication 2803 2822	Candida specieswere
T43	tradename 2904 2912	AMPHOTEC
T44	tradename 2967 2975	AMPHOTEC
T45	indication 3160 3170	antifungal
T46	tradename 3293 3301	AMPHOTEC
T47	indication 3337 3397	Aspergillus fumigatus, Candida albicans, Coccidioidesimmitis
T48	indication 3402 3426	Cryptococcus neoformans,
T49	indication 3470 3483	aspergillosis
T50	tradename 3599 3607	AMPHOTEC
T51	indication 3646 3669	visceral leishmaniasis,
T52	indication 3787 3798	Leishmania.
T53	activeingredient 3993 4007	amphotericin B
T54	activeingredient 4327 4341	amphotericin B
T55	tradename 4366 4375	AMPHOTEC.
T56	activeingredient 4437 4452	amphotericin B,
T57	tradename 4469 4478	AMPHOTEC,
T58	indication 4534 4561	systemic fungal infections.
T59	tradename 4676 4684	AMPHOTEC
T60	dose 4702 4718	0.5 to 8.0 mg/kg
T61	frequency 4718 4723	/day.
T62	activeingredient 4764 4778	amphotericin B
T63	activeingredient 4809 4823	amphotericin B
T64	activeingredient 4884 4898	amphotericinB.
T65	activeingredient 5014 5029	amphotericin B,
T66	tradename 5046 5055	AMPHOTEC,
T67	activeingredient 5145 5160	amphotericin B,
T68	tradename 5184 5185	,
T69	dose 5399 5415	0.5 to 8.0 mg/kg
T70	frequency 5415 5420	/day.
T71	tradename 5812 5820	AMPHOTEC
T72	activeingredient 5903 5917	Amphotericin B
T73	tradename 5960 5968	AMPHOTEC
T74	tradename 5973 5981	AMPHOTEC
T75	activeingredient 6135 6149	amphotericin B
T76	tradename 6191 6199	AMPHOTEC
T77	volumeofdistribution 6511 6528	(L/kg) 3.8 4.1CLt
T78	clearance 6529 6561	(L/h/kg) 0.105 0.112Distribution
T79	plasmahalflife 6572 6600	(minutes) 3.5 3.5Elimination
T80	eliminationhalflife 6611 6632	(hours) 27.5 28.2Cmax
T81	cmax 6633 6652	(g/mL) 2.6 2.9AUCss
T82	auc 6653 6674	(g/mL&#x2022;h) 29 36
T83	activeingredient 6712 6727	amphotericin B,
T84	indication 6884 6895	 infections
T85	activeingredient 7138 7153	amphotericin B,
T86	activeingredient 7393 7407	Amphotericin B
T87	dose 7450 7457	1 mg/kg
T88	activeingredient 7734 7736	 B
T89	volumeofdistribution 8121 8134	(L/kg) 1.1CLt
T90	clearance 8135 8161	(L/h/kg) 0.028Distribution
T91	plasmahalflife 8172 8195	(minutes) 38Elimination
T92	eliminationhalflife 8206 8220	(hours) 39Cmax
T93	cmax 8221 8236	(g/mL) 2.9AUCss
T94	auc 8237 8255	(g/mL&#x2022;h) 36
T95	activeingredient 8312 8326	amphotericin B
T96	tradename 8334 8342	AMPHOTEC
T97	activeingredient 8366 8368	 B
T98	activeingredient 8622 8636	amphotericin B
T99	tradename 8680 8688	AMPHOTEC
T100	tradename 8957 8965	AMPHOTEC
T101	activeingredient 9078 9093	amphotericin B,
T102	tradename 9110 9119	AMPHOTEC,
T103	tradename 9371 9379	AMPHOTEC
T104	activeingredient 9445 9460	amphotericin B,
T105	tradename 9477 9486	AMPHOTEC,
T106	tradename 9784 9795	AMPHOTEChas
T107	activeingredient 9842 9857	amphotericin B,
T108	tradename 9874 9883	AMPHOTEC,
T109	tradename 10036 10036	
T110	indication 10071 10093	invasive aspergillosis
T111	indication 10242 10264	invasive aspergillosis
T112	indication 10377 10395	Aspergillos isData
T113	indication 10438 10459	aspergillus infection
T114	tradename 10591 10599	AMPHOTEC
T115	activeingredient 11724 11738	amphotericin B
T116	tradename 11789 11800	AMPHOTECfor
T117	tradename 13174 13183	AMPHOTEC.
T118	frequency 13221 13226	daily
T119	dose 13236 13243	4 mg/kg
T120	frequency 13243 13247	/day
T121	dose 13255 13271	0.73 - 7.5 mg/kg
T122	frequency 13271 13276	/day)
T123	dose 13311 13316	6.3 g
T124	dose 13324 13342	0.36 - 34.4 grams)
T125	duration 13377 13385	24 days(
T126	duration 13391 13404	5 - 129 days)
T127	dose 13733 13741	15 mg/kg
T128	tradename 14431 14439	AMPHOTEC
T129	indication 14487 14509	invasive aspergillosis
T130	tradename 14725 14733	AMPHOTEC
T131	tradename 15613 15613	
T132	dose 16525 16532	4 mg/kg
T133	frequency 16532 16536	/day
T134	tradename 16540 16548	AMPHOTEC
T135	dose 16552 16561	0.8 mg/kg
T136	frequency 16561 16565	/day
T137	duration 16613 16621	14 days.
T138	tradename 16717 16725	AMPHOTEC
T139	tradename 17171 17179	AMPHOTEC
T140	tradename 17763 17763	
T141	tradename 18082 18082	
T142	tradename 18249 18257	AMPHOTEC
T143	adversereaction 18316 18316	
T144	activeingredient 18378 18393	amphotericin B-
T145	adversereaction 18433 18444	anaphylaxis
T146	routeofadministration 18505 18516	intravenous
T147	tradename 18724 18733	AMPHOTEC.
T148	tradename 18747 18756	AMPHOTEC.
T149	tradename 18783 18783	
T150	routeofadministration 18807 18821	intravenously.
T151	adversereaction 18864 18907	fever,chills, hypoxia, hypotension, nausea,
T152	adversereaction 18911 18921	tachypnea,
T153	routeofadministration 18960 18979	intravenousinfusion
T154	tradename 19071 19071	
T155	routeofadministration 19356 19367	intravenous
T156	tradename 19642 19650	AMPHOTEC
T157	activeingredient 19731 19746	amphotericin B;
T158	tradename 19794 19803	AMPHOTEC.
T159	activeingredient 19868 19882	amphotericin B
T160	adversereaction 19913 19941	renal toxicity,bronchospasm,
T161	adversereaction 19946 19958	hypotension.
T162	tradename 20031 20040	AMPHOTEC.
T163	activeingredient 20144 20158	amphotericin B
T164	adversereaction 20184 20184	
T165	adversereaction 20223 20243	cardiac dysfunction.
T166	tradename 20307 20316	AMPHOTEC,
T167	tradename 20466 20474	AMPHOTEC
T168	activeingredient 20479 20505	amphotericin Bdeoxycholate
T169	tradename 21153 21161	AMPHOTEC
T170	activeingredient 21240 21254	amphotericin B
T171	tradename 21427 21435	AMPHOTEC
T172	activeingredient 21502 21516	amphotericin B
T173	activeingredient 21577 21591	amphotericin B
T174	tradename 21713 21722	AMPHOTEC,
T175	activeingredient 21820 21834	amphotericin B
T176	tradename 22041 22050	AMPHOTEC.
T177	activeingredient 22145 22159	amphotericin B
T178	activeingredient 22434 22448	amphotericin B
T179	tradename 22636 22645	AMPHOTEC.
T180	activeingredient 22801 22804	 B-
T181	adversereaction 22812 22823	hypokalemia
T182	adversereaction 22914 22926	hypokalemia.
T183	tradename 22999 23000	,
T184	tradename 23168 23176	AMPHOTEC
T185	tradename 23243 23251	AMPHOTEC
T186	tradename 23530 23538	AMPHOTEC
T187	tradename 23656 23664	AMPHOTEC
T188	tradename 24135 24144	AMPHOTEC.
T189	tradename 24170 24178	AMPHOTEC
T190	tradename 24373 24382	AMPHOTEC.
T191	tradename 24553 24561	AMPHOTEC
T192	tradename 24722 24730	AMPHOTEC
T193	activeingredient 24830 24845	amphotericin B,
T194	tradename 24924 24933	AMPHOTEC,
T195	tradename 25096 25105	AMPHOTEC,
T196	tradename 25298 25306	AMPHOTEC
T197	tradename 25437 25445	AMPHOTEC
T198	adversereaction 25456 25470	nephrotoxicity
T199	adversereaction 25555 25569	Renal toxicity
T200	tradename 25818 25827	AMPHOTEC.
T201	tradename 25957 25965	AMPHOTEC
T202	indication 26011 26038	systemic fungal infections,
T203	frequency 26071 26076	daily
T204	dose 26085 26096	3 - 6mg/kg.
T205	tradename 26151 26159	AMPHOTEC
T206	dose 26161 26173	4 or 6 mg/kg
T207	frequency 26173 26178	/day)
T208	dose 26215 26229	0.8 or 1 mg/kg
T209	frequency 26229 26234	/day)
T210	routeofadministration 26503 26503	
T211	tradename 26581 26590	AMPHOTEC.
T212	tradename 26798 26807	AMPHOTEC,
T213	tradename 26950 26958	AMPHOTEC
T214	tradename 27064 27072	AMPHOTEC
T215	tradename 27240 27256	AMPHOTECPatients
T216	tradename 27319 27328	AMPHOTEC(
T217	tradename 27337 27358	AMPHOTECAspergillosis
T218	indication 27358 27358	
T219	tradename 27378 27387	AMPHOTEC(
T220	adversereaction 27452 27458	Chills
T221	adversereaction 27475 27480	Fever
T222	adversereaction 27497 27505	Headache
T223	adversereaction 27518 27534	Chills and fever
T224	adversereaction 27568 27579	Hypotension
T225	adversereaction 27594 27605	Tachycardia
T226	adversereaction 27620 27632	Hypertension
T227	adversereaction 27661 27667	Nausea
T228	tradename 27686 27694	AMPHOTEC
T229	dose 27696 27708	4 or 6 mg/kg
T230	frequency 27708 27713	/day)
T231	dose 27747 27761	0.8 or 1 mg/kg
T232	frequency 27761 27766	/day)
T233	adversereaction 28048 28054	Nausea
T234	adversereaction 28068 28087	Nausea and vomiting
T235	adversereaction 28101 28109	Vomiting
T236	adversereaction 28123 28151	Liver function test abnormal
T237	adversereaction 28191 28207	Thrombocytopenia
T238	adversereaction 28251 28271	Creatinine increased
T239	adversereaction 28292 28303	Hypokalemia
T240	adversereaction 28318 28332	Hypomagnesemia
T241	adversereaction 28346 28364	Hyperbilirubinemia
T242	adversereaction 28379 28409	Alkaline phosphatase increased
T243	adversereaction 28422 28435	Hyperglycemia
T244	adversereaction 28466 28473	Dyspnea
T245	adversereaction 28486 28493	Hypoxia
T246	tradename 28576 28584	AMPHOTEC
T247	adversereaction 28689 28838	Abdomen enlarged, abdominal pain, back pain, chest pain, face edema, injection site inflammation,mucous membrane disorder, pain, sepsisCardiovascular
T248	adversereaction 28859 28911	 disorder, hemorrhage, postural hypotensionDigestive
T249	adversereaction 28926 28977	, dry mouth, hematemesis, jaundice, stomatitisHemic
T250	adversereaction 29004 29058	, coagulation disorder, prothrombin decreasedMetabolic
T251	adversereaction 29089 29178	, generalized edema, hypocalcemia, hypophosphatemia, peripheral edema, weight gainNervous
T252	adversereaction 29194 29265	, dizziness, insomnia, somnolence, thinking abnormal, tremorRespiratory
T253	adversereaction 29277 29360	, asthma, cough increased, epistaxis, hyperventilation, lung disorder, rhinitisSkin
T254	adversereaction 29376 29427	Maculopapular rash, pruritis, rash, sweatingSpecial
T255	adversereaction 29437 29470	 hemorrhageUrogenitalHematuriaThe
T256	tradename 29530 29538	AMPHOTEC
T257	tradename 29604 29612	AMPHOTEC
T258	adversereaction 29651 29822	Accidental injury, allergic reaction, asthenia, death, hypothermia, immune system disorder, infection,injection site pain, injection site reaction, neck painCardiovascular
T259	adversereaction 29839 30049	, atrial fibrillation, bradycardia, congestive heart failure, heart arrest, phlebitis, shock,supraventricular tachycardia, syncope, vasodilatation, venoocclusive liver disease, ventricularextrasystolesDigestive
T260	adversereaction 30064 30326	, bloody diarrhea, constipation, dyspepsia, fecal incontinence, gamma glutamyl transpeptidaseincreased, gastrointestinal disorder, gastrointestinal hemorrhage, gingivitis, glossitis, hepatic failure,melena, mouth ulceration, oral moniliasis, rectal disorderHemic
T261	adversereaction 30357 30469	, fibrinogen increased, hypochromic anemia, leukocytosis, leukopenia, petechia,thromboplastin decreasedMetabolic
T262	adversereaction 30503 30735	, BUN increased, dehydration, hyponatremia, hyperkalemia, hyperlipemia, hypernatremia,hypervolemia, hypoglycemia, hypoproteinemia, lactic dehydrogenase increased, AST (SGOT)increased, ALT (SGPT) increased, weight lossMusculoskeletal
T263	adversereaction 30752 30768	, myalgiaNervous
T264	adversereaction 30784 30929	, anxiety, convulsion, depression, hallucinations, hypertonia, nervousness, neuropathy,paresthesia, psychosis, speech disorder, stuporRespiratory
T265	adversereaction 30946 31026	, lung edema, pharyngitis, pleural effusion, respiratory disorder, sinusitisSkin
T266	adversereaction 31045 31170	, alopecia, petechial rash, skin discoloration, skin disorder, skin nodule, skin ulcer, urticaria,vesiculobullous rashSpecial
T267	adversereaction 31186 31220	, deafness, ear disorder, tinnitus
T268	adversereaction 31249 31360	, dysuria, glycosuria, kidney failure, oliguria, urinary incontinence, urinary retention,urinary tract disorder
T269	tradename 31379 31379	
T270	dose 31576 31587	3 - 4 mg/kg
T271	tradename 31612 31621	AMPHOTEC,
T272	routeofadministration 31723 31734	intravenous
T273	tradename 32401 32401	
T274	activeingredient 32608 32610	 B
T275	tradename 33046 33046	
T276	tradename 33078 33078	
T277	tradename 33575 33584	AMPHOTEC.
T278	tradename 33628 33637	AMPHOTEC.
T279	tradename 33816 33825	AMPHOTEC,
T280	tradename 34620 34620	
T281	activeingredient 34622 34637	Amphotericin B)
T282	tradename 34782 34790	AMPHOTEC
T283	dose 34791 34796	50 mg
T284	tradename 34829 34837	AMPHOTEC
T285	dose 34838 34844	100 mg
T286	tradename 34908 34916	AMPHOTEC
T287	tradename 34936 34944	AMPHOTEC
T288	company 35012 35041	Ben Venue Laboratories, Inc.,
T289	company 35080 35096	InterMune, Inc.,
T290	u.s.patent 35136 35179	4,822,777; 5,032,582; 5,194,266; 5,077,057.
T291	indication 35318 35341	invasive aspergillosis.
T292	tradename 35392 35400	AMPHOTEC
T293	activeingredient 35402 35416	amphotericin b
T294	nanoparticle 35428 35441	lipid complex
T295	routeofadministration 35563 35574	INTRAVENOUS
T296	activeingredient 35669 35686	a mpho teric in B
T297	activeingredient 35707 35723	ampho teric in B
T298	inactiveingredient 35806 35835	so dium cho lesteryl sulfa te
T299	inactiveingredient 35862 35873	 metha mine
T300	inactiveingredient 35918 35944	 dium edeta te dihydra te
T301	inactiveingredient 35971 35994	 cto se mo no hydra te
T302	inactiveingredient 36040 36057	 chlo ric a c id
T303	tradename 36215 36223	AMPHOTEC
T304	activeingredient 36225 36239	amphotericin b
T305	nanoparticle 36251 36264	lipid complex
T306	routeofadministration 36386 36397	INTRAVENOUS
T307	activeingredient 36492 36510	a mpho. teric in B
T308	activeingredient 36531 36547	ampho teric in B
T309	inactiveingredient 36632 36661	so dium cho lesteryl sulfa te
T310	inactiveingredient 36688 36699	 metha mine
T311	inactiveingredient 36745 36771	 dium edeta te dihydra te
T312	inactiveingredient 36798 36821	 cto se mo no hydra te
T313	inactiveingredient 36869 36886	 chlo ric a c id
T314	company 37054 37085	InterMune, Inc. InterMune, Inc.
T315	tradename 37103 37111	AMPHOTEC
T316	activeingredient 37112 37126	Amphotericin B
T317	adversereaction 37549 37576	Hypokalemia Hypomagnesemia
